Donna had never even heard of PRP eye drops for severe dry eye. She only knew that she had to do something. “My eyes are so dry they feel like sandpaper,” said Donna (name changed to protect patient privacy). “I’ve tried every kind of eye drop available, from steroids to artificial tears. Nothing has helped.”
When Severe Dry Eye Takes Over Daily Life
Donna made an appointment with Oregon Regenerative Medicine after everything else had failed. It felt like her last chance to regain her quality of life.
“I love to read, but my eyes burn so badly I can only manage a few pages before I have to stop.”
Her symptoms had become relentless. Burning, itching and irritation followed her throughout the day, and she had been told that she might simply have to live with the discomfort.

What Are PRP Eye Drops?
At her first appointment, we prepared PRP eye drops for dry eyes from Donna’s own blood. PRP stands for platelet-rich plasma. It contains concentrated platelets and naturally occurring proteins that help support tissue repair.
A 2025 study of 96 patients1 found that undiluted PRP eye drops contained higher levels of epidermal growth factor, basic fibroblast growth factor and beta-nerve growth factor than autologous serum drops. These factors play roles in maintaining and repairing the ocular surface.
What Does Research Say About PRP Eye Drops?
Evidence for PRP eye drops has grown since Donna first received treatment. In a 2024 randomized trial of 96 adults2 with moderate-to-severe dry eye disease, PRP reduced symptoms and ocular-surface staining about as well as autologous serum, another blood-derived treatment, after four weeks. Average symptom scores improved by roughly 22 points.
A 2024 network meta-analysis3 of 16 randomized trials involving 898 patients found that PRP eye drops performed better than artificial tears for corneal staining and dry eye symptoms. More recently, a small 2026 randomized trial4 reported that both PRP and autologous serum produced greater improvements than sodium hyaluronate drops. PRP showed stronger gains in symptom scores, tear production and ocular-surface staining.
The research remains encouraging, although preparation methods vary and larger, longer-term trials are still needed.5)
What to Expect with PRP Eye Drops
When Donna returned three months later, she reported that the burning pain, itching and other symptoms had improved. She initially used the drops four to six times per day. By her follow-up, she needed them only two to three times per day and could read for an hour without discomfort.
Her dry eye questionnaire score dropped from 12 to 4—a 66% improvement. Although she had initially hesitated to pay out of pocket, she gladly purchased a refill. “This is well worth the money,” she said.
“I had lost hope,” Donna reflected. “It was so constant that it wore me down and really took away from my ability to live the life I want to live. I’d recommend anyone who has given up hope to try PRP eye drops. They gave me back my life.”
Donna’s experience is one patient’s story, and individual results vary. Because dry eye has several possible causes, a clinician should confirm the diagnosis and coordinate care with your eye doctor. To learn more, read Dry Eye Disease: PRP Results Are Clear or schedule an evaluation at Oregon Regenerative Medicine in Lake Oswego. Oregon Regenerative Medicine’s existing dry-eye guidance also recommends established ophthalmology care for baseline and follow-up testing.
Updated August 2026
Sources
- Jongkhajornpong, P., Lekhanont, K., Rattanasiri, S. et al. Comparison of Corneal Epitheliotrophic Factors of Undiluted Autologous Platelet-Rich Plasma and Autologous Serum Eye Drops for Dry Eye Disease. Ophthalmol Ther 14, 363–377 (2025). https://doi.org/10.1007/s40123-024-01082-y
- Jongkhajornpong P, Lekhanont K, Rattanasiri S, Numthavaj P, McKay G, Attia J, Thakkinstian A. Efficacy of 100% autologousplatelet-rich plasma and 100% autologous serum in dry eye disease: a randomised controlled trial. BMJ Open Ophthalmol. 2024 Oct 8;9(1):e001857. doi: 10.1136/bmjophth-2024-001857. PMID: 39384222; PMCID: PMC11474780.
- Zhang Y, Li N, Ge Z, Li F. Blood component therapy for dry eye disease: a systematic review and network meta-analysis. Front Med (Lausanne). 2024 Dec 16;11:1500160. doi: 10.3389/fmed.2024.1500160. PMID: 39736981; PMCID: PMC11683103.
- Mandour SS, Mariey H, Elgyoshy A, Fayed AS. Autologous platelet-rich plasma versus autologous serum in treatment of dry eye disease. Graefes Arch Clin Exp Ophthalmol. 2026 Jul;264(7):2097-2104. doi: 10.1007/s00417-026-07170-y. Epub 2026 Mar 31. PMID: 41915052; PMCID: PMC13342142.
- Mederle AL, Andrei D, Ghenciu LA, Stoicescu ER, Iacob R, Haţegan OA. Comparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-Analysis. Biomedicines. 2025 Sep 22;13(9):2316. doi: 10.3390/biomedicines13092316. PMID: 41007877; PMCID: PMC12467125.
Photos by Anthony Tran and Marina Vitale on Unsplash

